Alpa Laboratories Ltd

NSE: ALPA · BSE: 532878 · Pharmaceuticals & Biotechnology · 17 announcements

Share price: ₹57.71
Market cap: ₹121.4 Cr
Revenue (annual): ₹105.8 Cr
Net profit (annual): ₹14.13 Cr
P/E (TTM): 34.8×Sector 47.3×
Promoter holding: 57.19%+0.00% QoQ
FII holding: 0.35%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Management Change 7 Financial Results 3 Board Meeting Date 2 Results Correction 1 Price Movement Clarification 1 Other Announcement 1 Merger & Restructuring 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

13 Aug 2026 20:30 IST BSE

Financial Results

Alpa Laboratories Q1 FY27 Results: Net Profit ₹1 Cr, Down 91.5% YoY

Alpa Laboratories Ltd reported revenue from operations of ₹23.9 Cr (+25.1% YoY) and net profit of ₹1 Cr (-91.5% YoY) for Q1 FY27.

Key figure: Net profit ₹1 Cr · -91.5% YoY

Open full results → Read the filing ↗

29 May 2026 22:32 IST BSE

Financial Results

Alpa Laboratories Q4 FY26 Results: Turns Profitable, Net Profit ₹1.4 Cr

Alpa Laboratories Ltd reported revenue from operations of ₹31.4 Cr (-21.3% YoY) and net profit of ₹1.4 Cr for Q4 FY26.

Key figure: Net profit ₹1.4 Cr

Open full results → Read the filing ↗

29 May 2026 22:31 IST BSE

Financial Results

Alpa Laboratories Financial Results

Alpa Laboratories reported audited financial results for the year ended March 31, 2026. The board also appointed new internal and cost auditors for the upcoming fiscal year.

Read the filing ↗